Geode Capital Management’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
Other funds holding EDSA
VCIM
RCMNY
PA
VCM
VFT
SRL
SCM
Geode Capital Management's EDSA Position: Q1 2026 in Review
Geode Capital Management increased its Edesa Biotech (EDSA) stake by 66% in Q1 2026, buying an estimated $91.5K and bringing the position to 77,054 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.
Geode Capital Management first reported a position in EDSA in Q1 2021 and has held it in 21 quarters since. The position peaked at $570K in Q3 2021. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.
- Geode Capital Management held 77,054 shares of Edesa Biotech worth $403K as of Q1 2026.
- Geode Capital Management bought 30,517 Edesa Biotech shares in Q1 2026, an estimated $91.5K.
- Edesa Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3664 holding.
- Geode Capital Management first reported a position in Edesa Biotech in Q1 2021 and has held it in 21 quarters since.
- Geode Capital Management's Edesa Biotech position peaked at $570K in Q3 2021.
- 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.